The rising popularity in GLP-1 agonists for diabetes has sparked a debate about formats: skin-applied devices versus tablets . Typically, GLP-1 treatments were solely available in oral form, but the https://owainpygw308745.imblogs.net/90760878/glp-1-skin-applications-vs-oral-medications-what-best-for-the-patient